Search research articles
Contact Us
Filters
Showing results (1-10 of 106) with videos related to
Page
of 11
Sort By:
Gastroenterology & Hepatology
|
May 26, 2021
Genetics of Nonalcoholic Steatohepatitis
Arun Sanyal
Cardiovascular Endocrinology
|
October 25, 2019
Nonalcoholic fatty liver disease: implications for cardiovascular risk
Amreen Dinani, Arun Sanyal
Journal of Diabetes
|
July 24, 2015
Is there a relationship between hepatitis B surface antibody status and diabetes?
Mandana Khalili, Arun Sanyal
Journal of Gastroenterology and Hepatology
|
November 3, 2010
Improving survival in patients with decompensated cirrhosis
Deepak Amarapurkar, Arun Sanyal
Current Pathobiology Reports
|
January 10, 2015
Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players
Robert Vincent, Arun Sanyal
F1000Research
|
June 28, 2018
Recent advances in understanding and managing non-alcoholic fatty liver disease
Somaya Albhaisi, Arun Sanyal
Seminars in Respiratory and Critical Care Medicine
|
June 23, 2006
Intensive management of hepatic failure
Mary E Rinella, Arun Sanyal
Cell Metabolism
|
January 9, 2020
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
Stefano Romeo, Arun Sanyal, Luca Valenti
Annual Review of Pharmacology and Toxicology
|
October 24, 2017
Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies
Julia Wattacheril, Danny Issa, Arun Sanyal
Journal of Hepatology
|
April 29, 2015
Current efforts and trends in the treatment of NASH
Vlad Ratziu, Zachary Goodman, Arun Sanyal
Page
of 11
Search research articles
Search
Showing results (1-10 of 106) with videos related to
Sort By:
Page
of 11
Gastroenterology & Hepatology
|
May 26, 2021
Genetics of Nonalcoholic Steatohepatitis
Arun Sanyal
Cardiovascular Endocrinology
|
October 25, 2019
Nonalcoholic fatty liver disease: implications for cardiovascular risk
Amreen Dinani, Arun Sanyal
Journal of Diabetes
|
July 24, 2015
Is there a relationship between hepatitis B surface antibody status and diabetes?
Mandana Khalili, Arun Sanyal
Journal of Gastroenterology and Hepatology
|
November 3, 2010
Improving survival in patients with decompensated cirrhosis
Deepak Amarapurkar, Arun Sanyal
Current Pathobiology Reports
|
January 10, 2015
Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players
Robert Vincent, Arun Sanyal
F1000Research
|
June 28, 2018
Recent advances in understanding and managing non-alcoholic fatty liver disease
Somaya Albhaisi, Arun Sanyal
Seminars in Respiratory and Critical Care Medicine
|
June 23, 2006
Intensive management of hepatic failure
Mary E Rinella, Arun Sanyal
Cell Metabolism
|
January 9, 2020
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
Stefano Romeo, Arun Sanyal, Luca Valenti
Annual Review of Pharmacology and Toxicology
|
October 24, 2017
Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies
Julia Wattacheril, Danny Issa, Arun Sanyal
Journal of Hepatology
|
April 29, 2015
Current efforts and trends in the treatment of NASH
Vlad Ratziu, Zachary Goodman, Arun Sanyal
Page
of 11